These findings led to propose HJURP as an independent prognostic factor for BC, with a better predictive value than Ki67, able also to aid the prognosis of different molecular subtypes (i.e., normal-like, luminal, Erbb2, and basal) (Hu et al., 2010). This evidence concerns the gene ERBB2 and breast cancer.